4.6 Article

Familial risks in urolithiasis in the population of Sweden

期刊

BJU INTERNATIONAL
卷 121, 期 3, 页码 479-485

出版社

WILEY
DOI: 10.1111/bju.14096

关键词

kidney stones; ureter stones; bladder stones; heritability

资金

  1. Deutsche Krebshilfe
  2. ALF grants of Region Skane

向作者/读者索取更多资源

Objective To assess detailed familial risks for medically diagnosed urolithiasis (UL, urinary tract stone disease) based on nationwide hospital and population records. Patients/Subjects and Methods Subjects were identified from the Swedish Multigeneration Register in which there were 211 718 patients with UL. Standardised incidence ratios (SIRs) were calculated by comparison to individuals without a family history of UL. Results The highest familial SIRs were invariably found for the same (concordant) type of UL: 2.18 for kidney, 2.20 for ureter, and 1.93 for bladder. SIRs increased from 1.84, when one parent was affected, to 3.54 when both parents were affected, which was a multiplicative interaction. The SIR was 1.79 when one sibling was affected but it increased to 24.91 when two siblings were affected. Such excessive risks (5.2% of familial cases) are probably explained by high-penetrant genes. A low SIR of 1.29 between spouses suggested a minor contribution by shared environmental factors on the familial risk. Conclusions The results point to underlying genetic causes for the observed familial clustering and establish the genetic landscape of UL. Family histories should be taken in UL diagnostics and prevention could follow guidelines recommended for recurrent UL.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Autoimmune diseases as comorbidities for liver, gallbladder, and biliary duct cancers in Sweden

Kari Hemminki, Kristina Sundquist, Jan Sundquist, Asta Forsti, Vaclav Liska, Akseli Hemminki, Xinjun Li

Summary: This study found a significant association between autoimmune diseases and hepatobiliary cancers through long-term tracking in the Swedish population. Several autoimmune diseases, particularly autoimmune hepatitis and primary biliary cirrhosis, were strongly linked with hepatobiliary cancers. Therefore, it is important to manage autoimmune disease symptoms carefully in each patient and promote a healthy lifestyle.

CANCER (2023)

Article Oncology

Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements

Kari Hemminki, Asta Foersti, Vaclav Liska, Anna Kanerva, Otto Hemminki, Akseli Hemminki

Summary: By analyzing the 5-year relative survival rates of 23 solid cancers in Denmark, Finland, Norway, and Sweden over a 50-year period (1970-2019), we found that certain cancers showed a gradual improvement in survival rates, such as melanoma and breast, endometrial, and thyroid cancers. Additionally, oral, oropharyngeal, testicular, and prostate cancers also exhibited significant increases in survival rates. However, lung, esophageal, liver, and other cancers showed only minimal improvement.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Cell Biology

Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma

Yasmeen Niazi, Nagarajan Paramasivam, Joanna Blocka, Abhishek Kumar, Stefanie Huhn, Matthias Schlesner, Niels Weinhold, Rolf Sijmons, Mirjam De Jong, Brian Durie, Hartmut Goldschmidt, Kari Hemminki, Asta Foersti

Summary: Multiple myeloma (MM) is a plasma cell malignancy characterized by the over-propagation of a single clone of plasma cells in the bone marrow. The genetic basis of familial MM, particularly within the non-coding genome, is still not well understood. In this study, whole-genome sequencing data was used to identify and characterize variants in the non-coding genome of MM families. The findings confirmed previously implicated biological pathways in MM development and identified 10 genes involved in mitogen-activated protein kinase (MAPK) signaling pathways, which are known to be important in MM.
Article Biochemistry & Molecular Biology

GWAS-Identified Variants for Obesity Do Not Influence the Risk of Developing Multiple Myeloma: A Population-Based Study and Meta-Analysis

Jose Manuel Sanchez-Maldonado, Antonio Jose Cabrera-Serrano, Subhayan Chattopadhyay, Daniele Campa, Maria del Pilar Garrido, Angelica Macauda, Rob Ter Horst, Andres Jerez, Mihai G. G. Netea, Yang Li, Kari Hemminki, Federico Canzian, Asta Foersti, Juan Sainz

Summary: This study found that obesity-related genetic variants do not impact the risk of developing MM, based on genomic association studies conducted in German and Spanish populations.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?

Antonio Jose Cabrera-Serrano, Jose Manuel Sanchez-Maldonado, Rob ter Horst, Angelica Macauda, Paloma Garcia-Martin, Yolanda Benavente, Stefano Landi, Alyssa Clay-Gilmour, Yasmeen Niazi, Blanca Espinet, Juan Jose Rodriguez-Sevilla, Eva Maria Perez, Rossana Maffei, Gonzalo Blanco, Matteo Giaccherini, James R. Cerhan, Roberto Marasca, Miguel Angel Lopez-Nevot, Tzu Chen-Liang, Hauke Thomsen, Irene Gamez, Daniele Campa, Victor Moreno, Silvia de Sanjose, Rafael Marcos-Gragera, Maria Garcia-Alvarez, Trinidad Dierssen-Sotos, Andres Jerez, Aleksandra Butrym, Aaron D. Norman, Mario Luppi, Susan L. Slager, Kari Hemminki, Yang Li, Sonja I. Berndt, Delphine Casabonne, Miguel Alcoceba, Anna Puiggros, Mihai G. Netea, Asta Foersti, Federico Canzian, Juan Sainz

Summary: Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults worldwide. However, a study found that the GWAS-identified risk variants for CLL do not significantly impact overall survival and disease progression in CLL patients. The polygenic risk scores (PRSs) built with these risk variants also have limited accuracy in predicting patient survival and disease progression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

Esther Clavero, Jose Manuel Sanchez-Maldonado, Angelica Macauda, Rob Ter Horst, Belem Sampaio-Marques, Artur Jurczyszyn, Alyssa Clay-Gilmour, Angelika Stein, Michelle A. T. Hildebrandt, Niels Weinhold, Gabriele Buda, Ramon Garcia-Sanz, Waldemar Tomczak, Ulla Vogel, Andres Jerez, Daria Zawirska, Marzena Watek, Jonathan N. Hofmann, Stefano Landi, John J. Spinelli, Aleksandra Butrym, Abhishek Kumar, Joaquin Martinez-Lopez, Sara Galimberti, Maria Eugenia Sarasquete, Edyta Subocz, Elzbieta Iskierka-Jazdzewska, Graham G. Giles, Malwina Rybicka-Ramos, Marcin Kruszewski, Niels Abildgaard, Francisco Garcia Verdejo, Pedro Sanchez Rovira, Miguel Inacio da Silva Filho, Katalin Kadar, Malgorzata Razny, Wendy Cozen, Matteo Pelosini, Manuel Jurado, Parveen Bhatti, Marek Dudzinski, Agnieszka Druzd-Sitek, Enrico Orciuolo, Yang Li, Aaron D. Norman, Jan Maciej Zaucha, Rui Manuel Reis, Miroslaw Markiewicz, Juan Jose Rodriguez Sevilla, Vibeke Andersen, Krzysztof Jamroziak, Kari Hemminki, Sonja I. Berndt, Vicent Rajkumar, Grzegorz Mazur, Shaji K. Kumar, Paula Ludovico, Arnon Nagler, Stephen J. Chanock, Charles Dumontet, Mitchell J. Machiela, Judit Varkonyi, Nicola J. Camp, Elad Ziv, Annette Juul Vangsted, Elizabeth E. Brown, Daniele Campa, Celine M. Vachon, Mihai G. Netea, Federico Canzian, Asta Foersti, Juan Sainz

Summary: By conducting a meta-analysis on the germline genetic data of 234 autophagy-related genes from three independent study populations, we investigated the influence of autophagy-related variants on the risk of Multiple Myeloma (MM) and examined the functional mechanisms behind the observed associations. We identified SNPs within the six CD46, IKBKE, PARK2, ULK4, ATG5, and CDKN2A loci associated with MM risk and found that their effect on disease risk was mediated by specific subsets of immune cells, as well as vitamin D3-, MCP-2-, and IL20-dependent mechanisms.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances

Phanindra Babu Kasi, Venkata Ramana Mallela, Filip Ambrozkiewicz, Andriy Trailin, Vaclav Liska, Kari Hemminki

Summary: Colorectal cancer (CRC) is a common and fatal disease, with metastasis occurring most frequently in the liver and peritoneum. Conventional treatments have limited efficacy, necessitating the development of new diagnostic and therapeutic approaches. Nanotechnology offers promising nanomaterials for targeted drug delivery and diagnosis in CRC. Combining theranostic approaches with nanomedicine has the potential to revolutionize CRC detection and treatment. This review emphasizes recent studies, potential, and challenges in the development of nanoplatforms for CRC detection and treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Oncology

Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment

Kari Hemminki, Janne Hemminki, Asta Foersti, Amit Sud

Summary: Using data from four countries, a study shows that the survival rates for seven hematological malignancies have improved over half a century, thanks to advancements in diagnosis, risk stratification, and treatment.

LEUKEMIA (2023)

Article Oncology

Survival in gastric and esophageal cancers in the Nordic countries through a half century

Kari Hemminki, Filip Tichanek, Asta Foersti, Otto Hemminki, Akseli Hemminki

Summary: According to Nordic cancer data, the 1-year and 5-year relative survival rates for gastric cancer and esophageal cancer have increased from 1970 to 2019, with the most significant improvement seen in the 1-year survival rates. However, survival rates remain low for elderly patients.

CANCER MEDICINE (2023)

Article Public, Environmental & Occupational Health

Survival in Lung Cancer in the Nordic Countries Through A Half Century

Filip Tichanek, Asta Forsti, Otto Hemminki, Akseli Hemminki, Kari Hemminki

Summary: This study analyzed data on lung cancer survival over a 50-year period (1971-2020) in Denmark, Finland, Norway, and Sweden. The findings showed a significant improvement in lung cancer survival after the year 2000. The highest 5-year survival rate was observed in Norwegian men and women. This study may provide insights for better treatment and interventions for lung cancer patients.

CLINICAL EPIDEMIOLOGY (2023)

Article Oncology

Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers

Kari Hemminki, Kristina Sundquist, Jan Sundquist, Asta Foersti, Vaclav Liska, Akseli Hemminki, Xinjun Li

Summary: Liver cancer, including hepatocellular carcinoma, gallbladder cancer, and bile duct cancer, is influenced by various risk factors such as alcohol, viral hepatitis, gallstones, infections, autoimmune diseases, and diabetes. This study demonstrates that the combination of these risk factors can account for at least 50% of the causes of these cancers, highlighting the significance of chronic inflammation as an underlying mechanism. The use of national hospital records in Sweden provides valuable insights into the potential comorbidities associated with hepatobiliary cancers.

CANCERS (2023)

Article Psychology, Applied

Neighbourhood deprivation and type 2 diabetes in patients with bipolar disorder: A nationwide follow-up study

Xinjun Li, Filip Jansaker, Jan Sundquist, Kristina Sundquist

Summary: Patients with bipolar disorder living in high deprivation neighbourhoods have a significantly higher risk of developing type 2 diabetes compared to those living in low deprivation neighbourhoods.

STRESS AND HEALTH (2023)

Article Oncology

Conditional survival in breast cancer up to 10 years in the Nordic countries

Frantisek Zitricky, Asta Foersti, Akseli Hemminki, Kari Hemminki

Summary: This study modeled survival data from the NORDCAN database and analyzed survival rates of breast cancer patients in Denmark, Finland, Norway, and Sweden from 1971 to 2020. The results showed that Sweden had the highest survival rates, but all countries showed improvements over time and approached the levels of Sweden. The risk of recurrence was higher in the 2-5 year period, which resulted in higher 10/5-year survival rates compared to 5/1-year survival rates. The study suggests that late mortality is a critical factor limiting survival in breast cancer.

CANCER MEDICINE (2023)

Article Obstetrics & Gynecology

Survival, Incidence, and Mortality Trends in Female Cancers in the Nordic Countries

Filip Tichanek, Asta Foersti, Otto Hemminki, Akseli Hemminki, Kari Hemminki

Summary: This study analyzed 50 years of data and found that breast cancer had the highest 5-year survival rate, reaching 92.3%, followed by endometrial and cervical cancer at 86.1% and 75.6% respectively. Ovarian cancer showed the largest improvement in 5-year survival over the past 50 years, reaching 52.9% in the end. The overall survival for these female cancers has continuously improved, likely due to advancements in treatment, imaging techniques, and patient care organization.

OBSTETRICS AND GYNECOLOGY INTERNATIONAL (2023)

暂无数据